Classification of lupus nephritis

Current Opinion in Nephrology and Hypertension

Volumn 18, Issue 3, 2009, Pages 220-225

  Markowitz, Glen S ^a   D'Agati, Vivette D ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

ISN RPS 2003 classification; Lupus nephritis; Lupus podocytopathy

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADVANCED SCLEROSING LUPUS NEPHRITIS; CHRONICITY; CLINICAL ASSESSMENT TOOL; CRESCENTIC LUPUS NEPHRITIS; CYTOPLASM; DIFFUSE LUPUS NEPHRITIS; DISEASE CLASSIFICATION; FOCAL LUPUS NEPHRITIS; GLOMERULOSCLEROSIS; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; LUPUS PODOCYTOPATHY; MEMBRANOUS LUPUS NEPHRITIS; MESANGIAL LUPUS NEPHRITIS; MESANGIAL PROLIFERATIVE LUPUS NEPHRITIS; NECROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR LESION; ANIMAL; CELL PROLIFERATION; CLASSIFICATION; FOCAL GLOMERULOSCLEROSIS; IMMUNOLOGY; MEMBRANOUS GLOMERULONEPHRITIS; MESANGIUM; OBSERVER VARIATION; PATHOLOGY; PODOCYTE;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CELL PROLIFERATION; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; LUPUS NEPHRITIS; NEPHRITIS, INTERSTITIAL; OBSERVER VARIATION; PODOCYTES;

EID: 67049116117     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328327b379     Document Type: Review

References (27)

1. Pollak VE, Pirani C, Chwartz FD. The natural history of the renal manifestations of systemic lupus erythematosus. J Lab Clin Med 1964; 63:537-550.
2. Baldwin DS, Lowenstein J, Rothfield NJ, et al. The clinical course of pro-liferative and membranous forms of lupus nephritis. Ann Intern Med 1970; 73:929-940.
3. McCluskey RT. Lupus nephritis. In: Sommers SC, editor. Kidney Pathology Decennial 1965-1975. East Norwalk, CT: Appleton-Century-Crofts; 1975. pp. 435-450.
4. Weening JJ, D'Agati VD, Schwartz MM, et al. Classification of glomerulone-phritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65:521-530.
5. Weening JJ, D'Agati VD, Schwartz MM, et al. Classification of glomerulone-phritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15:241-250.
6. Churg J, Sobin LH. Renal disease: classification and atlas of glomerular disease. Tokyo: Igaku-Shoin; 1982.
7. Churg J, Bernstein J, Glassock RJ. Renal disease: classification and atlas of glomerular disease. 2nd ed. New York: Igaku-Shoin; 1995.
8. Furness PN, Taub N. Interobserver reproducibility and application of the ISN/RPS classification of lupus nephritis: a UK-wide study. Am J Surg Pathol 2006; 30:1030-1035.
9. Austin HA 3rd, Muenz LR, Joyce KM, et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25:689-695.
10. Schwartz MM, Lan SP, Bernstein J, et al. Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Am J Kidney Dis 1993; 21:374-377.
11. Korbet SM, Lewis EJ, Schwartz MM, et al. Factors predictive of outcome in severe lupus nephritis. Am J Kidn Dis 2000; 35:904-914.
12. Hiramatsu N, Kuroiwa T, Ikeuchi H, et al. Revised classification of lupus nephritis is value in predicting outcome with an indication of the proportion of glomeruli affected by chronic lesions. Rheumatol 2008; 47:702-707. This study found similar outcomes for lupus nephritis class IV-S and IV-G, but noted that chronic lesions in lupus nephritis class IV-G impart a significant negative impact on prognosis.
13. Hill GS, Delahousse M, Nochy D, et al. A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int 2000; 58:1160-1173.
14. Najafi CC, Korbet SM, Lewis EJ, et al. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 2001; 59:2156-2163.
15. MittalB, Hurwitz S, Rennke H, Singh AK. New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences? Am J Kidney Dis 2004; 44:1050-1059.
16. Yokoyama H, Wada T, Hara A, et al., and the Kanazawa Study Group for Renal Diseases and Hypertension. The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese. Kidney Int 2004; 66:2382-2388.
17. Hill GS, Delahousse M, Nochy D, Bariety J. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different patho-genesis. Kidney Int 2005; 68:2288-2297.
18. Kim YG, Kim HW, Cho YM, et al. The difference between lupus nephritis class IV-G and IV-S in Koreans: Focus on the response to cyclophosphamide induction treatment. Rheumatol 2008; 47:311-314. This study found that, following 6 months of treatment with intravenous cyclophosphamide, the complete remission rate for lupus nephritis class IV-S is better than for lupus nephritis class IV-G.
19. Schwartz MM, Korbet SM, Lewis EJ. The prognosis and pathogenesis of severe lupus nephritis. Nephrol Dial Transplant 2008; 23:1298-1306. This study argues that WHO class III>50% and WHO class IV are not congruent with ISN/RPS 2003 class IV-S and IV-G because many of the cases of WHO class III>50% meet criteria for lupus nephritis class IV-G.
20. Nasr SH, D'Agati VD, Park HR, et al. Necrotizing and crescentic lupus nephritis with antineutrophic cytoplasmic antibody seropositivty. C J Am Soc Nephrol 2008; 3:682-690. This study describes 10 patients with SLE, ANCA seropositivity, and renal biopsy findings most consistent with the combined effects of both lupus nephritis and ANCA-associated necrotizing and crescentic glomerulo-nephritis.
21. Sen D, Isenberg DA. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Lupus 2003; 12:651-658.
22. Galeazzi M, Morozzi G, Sebastiani GD, et al. Antineutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE. Clin Exp Rheu-matol 1998; 16:541-546.
23. Dube GK, Markowitz GS, Radhakrishnan J, et al. Minimal change disease in systemic lupus erythematosus. Clin Nephrol 2002; 57:120-126.
24. Hertig A, Droz D, Lesavre P, et al. SLE and idiopathic nephrotic syndrome: coincidence or not? Am J Kidn Dis 2002; 40:1179-1184.
25. Kraft SW, Schwartz MM, Korbet SM, Lewis EJ. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol 2004; 16:175-179.
26. Appel GB, Pirani CL, D'Agati VD. Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 1994; 4:1499-1515.
27. Banfi G, Bertani T, Boeri V, et al. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Am J Kidney Dis 1991; 18:240-248.